Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorErdogan M.A.
dc.contributor.authorCinar B.P.
dc.contributor.authorKılıç K.D.
dc.contributor.authorÇavuşoğlu T.
dc.contributor.authorYiğittürk G.
dc.contributor.authorÇetin E.Ö.
dc.contributor.authorErbas O.
dc.date.accessioned2019-08-13T12:10:23Z
dc.date.accessioned2019-08-13T15:52:51Z
dc.date.available2019-08-13T12:10:23Z
dc.date.available2019-08-13T15:52:51Z
dc.date.issued2018
dc.identifier.issn1303-5150
dc.identifier.urihttps://dx.doi.org/10.14704/nq.2018.16.7.1706
dc.identifier.urihttp://hdl.handle.net/11446/1746
dc.description.abstractButamirate has the possible effects on epileptic seizures, which is thought to perform central antitussive effect via medulla oblongata and nucleus tractus solitarius. In our study, these effects have been investigated on electrophysiological and clinical basis. 48 Sprague-Dawley rats were divided randomly into two groups for EEG recordings and behavioral assesment then these two groups divided to four groups: 6 for control, 6 for saline injection, 6 for relatively-low dose butamirate (5 mg/kg) and 6 for relatively-high dose butamirate (10 mg/kg) for each. Evaluation of the behavioral analyses after giving 70 mg/kg pentylenetetrazol (PTZ) first myoclonic jerk time and racine convulsion scales were analyzed, then in different rats for EEG recordings 35 mg/kg PTZ were given and spike percentages were evaluated in same doses of butamirate. In both 5 mg/kg and 10 mg/kg butamirate groups the FMJ onset times were statistically higher then the saline group, similarly both 5 and 10 mg/kg butamirate groups RCS scores were significantly lower than the saline group. In terms of spike percentages, 5 and 10 mg/kg butamirate were significantly lower than the saline group. As a result in our study, we showed that 5 and 10 mg/kg doses of butamirate have anticonvulsant effects on PTZ induced rats. © 2018, Anka Publishers. All rights reserved.en_US
dc.language.isoengen_US
dc.publisherAnka Publishersen_US
dc.identifier.doi10.14704/nq.2018.16.7.1706en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectButamirate citrateen_US
dc.subjectElectroencephalogramen_US
dc.subjectExperimental epilepsy modelen_US
dc.subjectPentylenetetrazolen_US
dc.titleDemonstration of PTZ-induced convulsive-reducing effect of butamirate citrateen_US
dc.typearticleen_US
dc.relation.journalNeuroQuantologyen_US
dc.departmentDBÜen_US
dc.identifier.issue7en_US
dc.identifier.volume16en_US
dc.identifier.startpage65en_US
dc.identifier.endpage69en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-tempDBÜen_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster